
Sign up to save your podcasts
Or


Jared, Vanessa and Adam are joined by Steve Maike, Chief Pharmacy Officer for Remedy Analytics (part of the Brown & Brown team), and Alan Pannier, Vice President of Strategy with SmithRx. The team leads a discussion around strategies and best practices for employers to help confront the rising costs of pharmaceuticals for employers. Pharmacy cost increases are projected to be 9.8% with specialty drugs leading that trend, up almost 13.5% in 2023. The team covers strategies from highlighting biosimilars, gene therapy, navigational resources and recent legislation directly impacting employers on their pharmacy plans.
Connect with the hosts:
Jared Bowcutt
Vanessa Longnecker
Adam Compton
By Brown & Brown5
2525 ratings
Jared, Vanessa and Adam are joined by Steve Maike, Chief Pharmacy Officer for Remedy Analytics (part of the Brown & Brown team), and Alan Pannier, Vice President of Strategy with SmithRx. The team leads a discussion around strategies and best practices for employers to help confront the rising costs of pharmaceuticals for employers. Pharmacy cost increases are projected to be 9.8% with specialty drugs leading that trend, up almost 13.5% in 2023. The team covers strategies from highlighting biosimilars, gene therapy, navigational resources and recent legislation directly impacting employers on their pharmacy plans.
Connect with the hosts:
Jared Bowcutt
Vanessa Longnecker
Adam Compton

227,821 Listeners

8,713 Listeners

15,958 Listeners

592 Listeners

23 Listeners

27,925 Listeners

112,356 Listeners

24,234 Listeners

145 Listeners

73,632 Listeners

48,005 Listeners

25 Listeners

40,222 Listeners

29,158 Listeners

18,423 Listeners